Nompharma Limited
11764276
Healthy
- Negative net worth (-10)
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
Persons with Significant Control
Mr Michael Nkanka
British · England · Age 3
Biocity Nottingham, Innovation Building Room 202, Nottingham, NG1 1GF
Notified 15/09/2022
Former PSCs
Mr Michael Nkanka
Ceased 15/11/2021
Mr Christopher Okwufulueze Chinakwe
Ceased 01/04/2022
CompanyRankvs 1569+ SIC 46460 peers40
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/01/2025
Net Worth
-£28k
Balance sheet strength
Cash
£2k
Cash in the bank
Net Current Assets
£670
Working capital
Current Assets
£16k
Current Liabilities
£15k
Fixed Assets
£291
Debtors
£14k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 1.04 | +£5k |
| 2024 | — | +£7k |
| 2023 | 0.99 | +£13k |
| 2022 | 0.50 | — |
| 2020 | 0.31 | — |
Derived from filed accounts. Not audited figures.